The pill version of Novo Nordisk’s (NVO) blockbuster drug Ozempic was found to cut the risk of heart attacks, strokes, and ...

Failed to import article template. Reason: Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app ...

With the rising demand for weight-loss medications, compounding pharmacies have been making headlines lately. On October 30, ...

As Novo Nordisk’s injectable diabetes-obesity duo Ozempic and Wegovy grab all the limelight, an oral version of the ...

You may have heard about — or maybe even experienced — the short-term side effects of Ozempic® — such as nausea, vomiting, ...

Viking Therapeutics Inc.’s stock rose 2% Friday as excitement continued to build about data on its oral weight-loss drug the ...

All doses of the two drugs are now listed as available in the U.S., per an FDA database, although the company cautioned ...

Researchers from Loyola University Chicago are adding to the growing evidence suggesting that medications like Ozempic can ...

On October 21, Novo Nordisk announced positive news on the cardiovascular benefits of its oral GLP-1R agonist, Rybelsus, ...

Semaglutide medications — such as Ozempic, the popular diabetes medication — have been linked to a reduced risk of ...

He elaborated, “Semaglutide injections (Ozempic and Wegovy) are given as subcutaneous injections once a week. Rybelsus is a ...

A significant update in these guidelines includes considering GLP-1 drugs, such as Wegovy and Ozempic, for patients with ...